ONX
6 FDA 510(k) clearances · Product code
289 daysmedian time to decision
375 days90th percentile
6clearances measured
FDA profile
- Official device name
- Ovarian Adnexal Mass Assessment Score Test System
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.6050
- Medical specialty
- Obstetrics/Gynecology
- Flags
- Third-party review eligible
- FDA definition
- An ovarian/adnexal mass assessment test is a devicem that measures one or more proteins in serum. It yields a single result for the likelihood that an adnexal pelvic mass in a woman, for whom surgery is planned, is malignant. The test isn for adjunctive use, in teh context of a negative primary clinical and radiological evaluation, to augmrent the identification of patienets whose gynecologic surgery requires oncology expertise and resources.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| ROMA Calculation Tool Using Elecsys Assays (K153607) | Roche Diagnostics | 2016-06-15 |
| Lumipulse G ROMA (K160090) | Fujirebio Diagnostics,Inc. | 2016-05-16 |
| ARCHITECT ROMA (K151502) | Fujirebio Diagnostics,Inc. | 2016-04-28 |
| OVA1 Next Generation (K150588) | Vermillion, Inc. | 2016-03-18 |
| ROMA (HE4 EIA + ARCHITECT CA 125 II) (K103358) | Fujirebio Diagnostics,Inc. | 2011-09-01 |
| OVA1 TEST (DEN090004) | Vermillion | 2009-09-11 |
Track ONX automatically
Every clearance here is in the API, with alerts when new ones post.